Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chantal Mathieu

Showing results (241-250 of 626) with videos related to

Pageof 63
Sort By:
Diabetes, Obesity & Metabolism|February 23, 2021
Long-term (52-week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT-2 studyEiichi Araki, Chantal Mathieu, Toshihiko Shiraiwa, et al.
Diabetes/Metabolism Research and Reviews|November 10, 2011
Preservation of recall immunity in anti-CD3-treated recent onset type 1 diabetes patientsGonnie M Alkemade, Robert Hilbrands, Evy Vandemeulebroucke, et al.
Diabetes, Obesity & Metabolism|February 16, 2018
Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: Post-hoc analysis of concomitant add-on versus sequential add-on to metformin and of triple versus dual therapy with metforminStefano Del Prato, Julio Rosenstock, Ricardo Garcia-Sanchez, et al.
Diabetes Care|May 22, 2025
Early Detection of β-Cell Decline Using Home Dried-Blood-Spot C-Peptide Levels in New-Onset Type 1 DiabetesA Emile J Hendriks, M Loredana Marcovecchio, Mark L Evans, et al.
Medical Care|June 22, 2010
Monitoring modifiable cardiovascular risk in type 2 diabetes care in general practice: the use of an aggregated z-scoreGeert Goderis, Liesbeth Borgermans, Jan Heyrman, et al.
Cells|May 13, 2023
NET Proteome in Established Type 1 Diabetes Is Enriched in Metabolic ProteinsSamal Bissenova, Darcy Ellis, Aïsha Callebaut, et al.
Clinical Chemistry and Laboratory Medicine|July 3, 2015
Performance of strip-based glucose meters and cassette-based blood gas analyzer for monitoring glucose levels in a surgical intensive care settingHelena Claerhout, Martine De Prins, Dieter Mesotten, et al.
Journal of Proteome Research|August 14, 2013
Glucagon-like peptide-1 protects human islets against cytokine-mediated β-cell dysfunction and death: a proteomic study of the pathways involvedDieter Rondas, Marco Bugliani, Wannes D'Hertog, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2002
An uncommon tumor in a renal graft recipient: a diagnostic and therapeutic challengeKathleen Claes, Dirk Kuypers, Pieter Evenepoel, et al.
Diabetes, Obesity & Metabolism|August 28, 2025
Impact of the era of diabetes onset in a national care system on the prevalence of retinopathy and microalbuminuria in people living with type 1 diabetes 15 years post-diagnosis: A cross-sectional, real-world observational studyAstrid Lavens, Christophe De Block, Philippe Oriot, et al.
Pageof 63

Showing results (241-250 of 626) with videos related to

Sort By:
Pageof 63
Diabetes, Obesity & Metabolism|February 23, 2021
Long-term (52-week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT-2 studyEiichi Araki, Chantal Mathieu, Toshihiko Shiraiwa, et al.
Diabetes/Metabolism Research and Reviews|November 10, 2011
Preservation of recall immunity in anti-CD3-treated recent onset type 1 diabetes patientsGonnie M Alkemade, Robert Hilbrands, Evy Vandemeulebroucke, et al.
Diabetes, Obesity & Metabolism|February 16, 2018
Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: Post-hoc analysis of concomitant add-on versus sequential add-on to metformin and of triple versus dual therapy with metforminStefano Del Prato, Julio Rosenstock, Ricardo Garcia-Sanchez, et al.
Diabetes Care|May 22, 2025
Early Detection of β-Cell Decline Using Home Dried-Blood-Spot C-Peptide Levels in New-Onset Type 1 DiabetesA Emile J Hendriks, M Loredana Marcovecchio, Mark L Evans, et al.
Medical Care|June 22, 2010
Monitoring modifiable cardiovascular risk in type 2 diabetes care in general practice: the use of an aggregated z-scoreGeert Goderis, Liesbeth Borgermans, Jan Heyrman, et al.
Cells|May 13, 2023
NET Proteome in Established Type 1 Diabetes Is Enriched in Metabolic ProteinsSamal Bissenova, Darcy Ellis, Aïsha Callebaut, et al.
Clinical Chemistry and Laboratory Medicine|July 3, 2015
Performance of strip-based glucose meters and cassette-based blood gas analyzer for monitoring glucose levels in a surgical intensive care settingHelena Claerhout, Martine De Prins, Dieter Mesotten, et al.
Journal of Proteome Research|August 14, 2013
Glucagon-like peptide-1 protects human islets against cytokine-mediated β-cell dysfunction and death: a proteomic study of the pathways involvedDieter Rondas, Marco Bugliani, Wannes D'Hertog, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2002
An uncommon tumor in a renal graft recipient: a diagnostic and therapeutic challengeKathleen Claes, Dirk Kuypers, Pieter Evenepoel, et al.
Diabetes, Obesity & Metabolism|August 28, 2025
Impact of the era of diabetes onset in a national care system on the prevalence of retinopathy and microalbuminuria in people living with type 1 diabetes 15 years post-diagnosis: A cross-sectional, real-world observational studyAstrid Lavens, Christophe De Block, Philippe Oriot, et al.
Pageof 63